Market Overview

T-Mobile's Q4 Results Top Street

Share:

T-Mobile US Inc (NASDAQ: TMUS) reported better-than-expected fourth quarter results as it added more customers and continue to take share from rivals like Verizon Communications Inc. (NYSE: VZ), AT&T Inc. (NYSE: T) and Sprint Corp (NYSE: S) via its promotional offers around the holiday season.

Following is a gist of T-Mobile’s fourth quarter performance:

  • Q4 EPS Up 32% to $0.45 EPS, Tops $0.29 Consensus
  • Q4 Revenue Up 23% to $10.18B Versus $9.84B Est.
  • Q4 Service Revenues Rises 11% to $7.2B
  • Total Q4 Net Additions At 2.1M
  • Total Q4 Branded Postpaid Net Additions At 1.2M
  • Branded Postpaid Phone Average Revenue per User (ARPU) Up 0.7% To $48.37
  • Q4 Branded Postpaid Phone Churn 1.28%, Down 18 Bps From Q4 2015
  • Sees 2017 Branded Postpaid Net Additions Of 2.4M to 3.4M
  • Sees 2017 Adjusted EBITDA Of $10.4B to $10.8B
  • Expects 2017 Capex Of $4.8B to $5.1B

“These results are proof that doing right by customers is also good for shareholders. Not only are customers flocking to T-Mobile, but we’re also producing rock-solid financial results,” John Legere, President and CEO of T-Mobile, said in a press release.

During the fourth quarter, T-Mobile unveiled several promotional offers, including a free iPhone 7 offer with eligible trade-in around Black Friday. As a result, T-Mobile added 933,000 postpaid phone subscribers.

“The competition just doesn’t get that customers want to come first! That’s three years in a row that we’ve added more than 8 million customers and taken all of the postpaid phone growth in the industry. The Un-carrier revolution continues in 2017!”, Legere added.

The strong results of T-Mobile comes as Sprint’s 80 percent plus shareholder SoftBank being “open” to all options, including a deal with T-Mobile, given the prospects of U.S. regulators allowing four operators to consolidate to three.

Shares of T-Mobile closed Monday’s trading at $60.90.

Posted-In: Earnings News Guidance Tech

 

Related Articles (S + T)

View Comments and Join the Discussion!

Did Buffalo Wild Wings Management Restore Confidence?

Curing Disease Is Bad For Business: How Do Big Pharma Companies Continue Their Growth?